Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization

Abstract
Rationally designed protein subunit vaccines are being developed for a variety of viruses including influenza, RSV, SARS-CoV-2, and HIV. These vaccines are based on stabilized versions of the primary targets of neutralizing antibodies on the viral surface, namely, viral fusion glycoproteins. While these immunogens display the epitopes of potent neutralizing antibodies, they also present epitopes recognized by non-neutralizing or weakly neutralizing (“off-target”) antibodies. Using our recently developed electron microscopy polyclonal epitope mapping approach, we have uncovered a phenomenon wherein off-target antibodies elicited by HIV trimer subunit vaccines cause the otherwise highly stabilized trimeric proteins to degrade into cognate protomers. Further, we show that these protomers expose an expanded suite of off-target epitopes, normally occluded inside the prefusion conformation of trimer, that subsequently elicit further off-target antibody responses. Our study provides critical insights for further improvement of HIV subunit trimer vaccines for future rounds of the iterative vaccine design process.
Funding Information
  • National Institutes of Health (UM1AI100663)
  • National Institutes of Health (UM1AI144462)
  • Bill and Melinda Gates Foundation (OPP1115782)
  • Bill and Melinda Gates Foundation (INV-002916)
  • Bill and Melinda Gates Foundation (OPP1170236)
  • Bill and Melinda Gates Foundation (OPP1206647)
  • Horizon 2020 Framework Programme (681137)
  • Bill and Melinda Gates Foundation (INV-002916)